Pioglitazone Inhibits the Expression of Inflammatory Cytokines From Both Monocytes and Lymphocytes in Patients With Impaired Glucose Tolerance
Authors:
Open Access
- 1 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (12) , 2312-2318
Abstract
Objective— The current study determines whether pioglitazone (PIO) therapy reduces both monocyte and lymphocyte inflammatory activity and their ability to induce inflammation in other tissues. Methods and Results— Monocyte and lymphocyte cytokine gene and protein expression of interleukin (IL)-6 were first shown to be greater in subjects with impaired glucose tolerance (IGT) than in subjects with normal glucose tolerance. Sixty-six IGT subjects were then randomized to 4,5 months of placebo or PIO therapy. After receiving PIO, subjects had lower triglycerides and higher HDL cholesterol ( P P Conclusion— These results demonstrate that PIO therapy in IGT can reduce proinflammatory gene and protein expression from both monocytes and lymphocytes. This intervention also reduces the inflammatory cross-talk between these immune cells and adipose tissue, which could in turn contribute to the metabolic improvements resulting from PIO therapy.Keywords
This publication has 33 references indexed in Scilit:
- Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes MellitusCirculation, 2008
- Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunctionJournal of Experimental Medicine, 2007
- The role of the adventitia in vascular inflammationCardiovascular Research, 2007
- Adipose Tissue and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- Macrophage-secreted factors induce adipocyte inflammation and insulin resistanceBiochemical and Biophysical Research Communications, 2006
- Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory ChangesArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) activation suppresses ischemic induction of Egr‐1 and its inflammatory gene targetsThe FASEB Journal, 2002